Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer

NP McCabe, BA Kerr, M Madajka, A Vasanji… - Neoplasia, 2011 - Elsevier
Prostate cancer preferentially metastasizes to bone, which is rich in structural and
matricellular proteins capable of altering prostate cancer progression. This study explores …
被引用次数：37 相关文章
[PDF] cyberleninka.org

[PDF][PDF] Augmented Osteolysis in SPARC-Deficient Mice with Bone-Residing

NP McCabe, BA Kerr - Prostate, 2011 - cyberleninka.org
Prostate cancer preferentially metastasizes to bone, which is rich in structural and
matricellular proteins capable of altering prostate cancer progression. This study explores …
[PDF] core.ac.uk

[PDF][PDF] Augmented Osteolysis in SPARC-Deficient Mice with Bone-Residing

NP McCabe, BA Kerr - Prostate, 2011 - core.ac.uk
Prostate cancer preferentially metastasizes to bone, which is rich in structural and
matricellular proteins capable of altering prostate cancer progression. This study explores …

Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer

NP McCabe, BA Kerr, M Madajka… - … (New York, NY), 2011 - pubmed.ncbi.nlm.nih.gov
Prostate cancer preferentially metastasizes to bone, which is rich in structural and
matricellular proteins capable of altering prostate cancer progression. This study explores …
[PDF] researchgate.net

[PDF][PDF] Augmented Osteolysis in SPARC-Deficient Mice with Bone-Residing

NP McCabe, BA Kerr - Prostate, 2011 - researchgate.net
Prostate cancer preferentially metastasizes to bone, which is rich in structural and
matricellular proteins capable of altering prostate cancer progression. This study explores …
[PDF] semanticscholar.org

[PDF][PDF] Augmented Osteolysis in SPARC-Deficient Mice with Bone-Residing

NP McCabe, BA Kerr - Prostate, 2011 - pdfs.semanticscholar.org
Prostate cancer preferentially metastasizes to bone, which is rich in structural and
matricellular proteins capable of altering prostate cancer progression. This study explores …

Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.

NP McCabe, BA Kerr, M Madajka, A Vasanji… - Neoplasia (New York …, 2011 - europepmc.org
Prostate cancer preferentially metastasizes to bone, which is rich in structural and
matricellular proteins capable of altering prostate cancer progression. This study explores …
[PDF] psu.edu

[PDF][PDF] Augmented Osteolysis in SPARC-Deficient Mice with Bone-Residing

NP McCabe, BA Kerr - Prostate, 2011 - Citeseer
Prostate cancer preferentially metastasizes to bone, which is rich in structural and
matricellular proteins capable of altering prostate cancer progression. This study explores …

[引用][C] Augmented Osteolysis in SPARC-Deficient Mice with Bone-Residing Prostate Cancer

NP McCabe, BA Kerr, M Madajka, A Vasanji… - Neoplasia, 2011 - cir.nii.ac.jp
Augmented Osteolysis in SPARC-Deficient Mice with Bone-Residing Prostate Cancer | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[HTML] nih.gov

[HTML][HTML] Augmented Osteolysis in SPARC-Deficient Mice with Bone-Residing Prostate Cancer

NP McCabe, BA Kerr, M Madajka, A Vasanji… - … (New York, NY), 2011 - ncbi.nlm.nih.gov
Prostate cancer preferentially metastasizes to bone, which is rich in structural and
matricellular proteins capable of altering prostate cancer progression. This study explores …